Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
AlgoTherapeutix
company
About
AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.
- Suresnes,Ile-de-France,France
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- €20M
- Industries
- Biotechnology,Information Technology,Pharmaceutical
- Founded date
- Jan 1, 2018
- Number Of Employee
- 1 - 10
- Operating Status
- Active
- Also Known As
- AlgoTx
AlgoTx creates solutions to help patients suffering from difficult-to-treat conditions. The organization accomplishes this by emphasizing conditions with no proven or licensed therapy and adapting treatment to the very particular needs of the people afflicted. ATX01's admission into Phase 2 in Chemotherapy-Induced Peripheral Neuropathy has been approved by the FDA. In the meanwhile, AlgoTx is investigating its potential in erythromelalgia, a rare and painful condition.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€22.60M $12M
AlgoTherapeutix has raised a total of
€22.60M $12M
in funding over 2 rounds. Their latest funding was raised on
Jan 14, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 14, 2022 | Series B | €20M | — | — | — | Detail |
| Nov 24, 2020 | Series A | $12M | 2 |
Bpifrance
|
— | Detail |
| Nov 20, 2019 | Seed | €2.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
AlgoTherapeutix is funded by 2 investors.
Bpifrance
and Omnes Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Bpifrance
|
Yes | Series A |
Omnes Capital
|
— | Series A |
Employee Profiles
Number of Employee Profiles
5
AlgoTherapeutix has 5 current employee profiles, including
Executive Philippe Picaut
Executive
Executive
Board member
Executive
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
